July 16, 2025 · Form 4 insider transaction
Taub Rebecca sold 5,800 shares of Madrigal Pharmaceuticals, Inc. at $354.61 per share, a transaction worth $2.06M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.12 to $355.09, inclusive.